Ceribell (CBLL) Other Non-Current Assets (2023 - 2026)
Ceribell (CBLL) posted Other Non-Current Assets of $3.5 million for Q1 2026, up 448.02% on a QoQ basis from $631000.0 in Q4 2025, and up 1479.0% year-over-year from $219000.0 in Q1 2025.
Ceribell (CBLL) Other Non-Current Assets (2023 - 2026) Analysis & Trends
Ceribell's Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 1479.0% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 1479.0% YoY) and the FY2025 annual result came in at $631000.0, up 190.78% from the prior year.
- Other Non-Current Assets was $3.5 million for Q1 2026 at Ceribell, up from $631000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.5 million in Q1 2026 and bottomed at $152000.0 in Q4 2023.
- A 4-year average of $971625.0 and a median of $331000.0 in 2025 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 42.76% — and 2026, when it soared 1479.0%.
- Ceribell's Other Non-Current Assets stood at $152000.0 in 2023, then jumped by 42.76% to $217000.0 in 2024, then surged by 190.78% to $631000.0 in 2025, then soared by 448.02% to $3.5 million in 2026.
- Business Quant data shows CBLL's Other Non-Current Assets at $3.5 million in Q1 2026, $631000.0 in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.05 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 285.90 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 828.89 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 164.00 Mn |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.46 Mn |
| Dec 31, 2025 | 631,000.00 |
| Sep 30, 2025 | 2.44 Mn |
| Jun 30, 2025 | 443,000.00 |
| Mar 31, 2025 | 219,000.00 |
| Dec 31, 2024 | 217,000.00 |
| Sep 30, 2024 | 217,000.00 |
| Dec 31, 2023 | 152,000.00 |